Experimental cord blood treatment offers hope for blood cancer patients
NCT ID NCT01451502
Summary
This study tests the safety of using unlicensed cord blood units for patients with blood cancers who need stem cell transplants. Researchers want to make sure these cord blood units don't transmit infections or cause serious reactions during infusion. The trial will track 250 patients receiving these unlicensed units as part of their cancer treatment at the University of Minnesota.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LYMPHATIC DISEASES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Masonic Cancer Center, University of Minnesota
RECRUITINGMinneapolis, Minnesota, 55455, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.